T. Rowe Price Associates’s Dentsply Sirona XRAY Stock Holding History

T. Rowe Price Associates’s Portfolio XRAY Stock Details XRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.32M	Buy	199,965 +16,292	+9%	+$203K	﹤0.01%	1761
2025 Q4	$2.1M	Sell	183,673 -13,699	-7%	-$161K	﹤0.01%	1728
2025 Q3	$2.5M	Sell	197,372 -10,749,500	-98%	-$156M	﹤0.01%	1639
2025 Q2	$174M	Sell	10,946,872 -3,014,887	-22%	-$45.1M	0.02%	461
2025 Q1	$209M	Buy	13,961,759 +1,412,517	+11%	+$25M	0.03%	405
2024 Q4	$238M	Buy	12,549,242 +1,975,404	+19%	+$41.8M	0.03%	390
2024 Q3	$286M	Buy	10,573,838 +3,567,011	+51%	+$91.1M	0.03%	365
2024 Q2	$175M	Buy	7,006,827 +740,046	+12%	+$21.2M	0.02%	444
2024 Q1	$208M	Buy	6,266,781 +343,915	+6%	+$11.7M	0.03%	414
2023 Q4	$211M	Sell	5,922,866 -156,367	-3%	-$4.96M	0.03%	413
2023 Q3	$208M	Sell	6,079,233 -938,921	-13%	-$35.7M	0.03%	384
2023 Q2	$281M	Sell	7,018,154 -784,172	-10%	-$31.2M	0.04%	336
2023 Q1	$306M	Buy	7,802,326 +1,224,984	+19%	+$45M	0.05%	307
2022 Q4	$209M	Buy	6,577,342 +23,998	+0.4%	+$723K	0.03%	369
2022 Q3	$186M	Sell	6,553,344 -3,434,653	-34%	-$117M	0.03%	372
2022 Q2	$357M	Buy	9,987,997 +905,001	+10%	+$36.6M	0.05%	346
2022 Q1	$447M	Sell	9,082,996 -1,772	-0%	-$93.7K	0.05%	350
2021 Q4	$507M	Sell	9,084,768 -10,114,115	-53%	-$556M	0.05%	349
2021 Q3	$1.11B	Buy	19,198,883 +853,451	+5%	+$52.6M	0.11%	200
2021 Q2	$1.16B	Buy	18,345,432 +2,546,458	+16%	+$168M	0.11%	197
2021 Q1	$1.01B	Buy	15,798,974 +6,036,611	+62%	+$350M	0.1%	221
2020 Q4	$511M	Buy	9,762,363 +183,590	+2%	+$9.05M	0.05%	325
2020 Q3	$419M	Buy	9,578,773 +3,590,178	+60%	+$159M	0.05%	327
2020 Q2	$264M	Buy	5,988,595 +175,932	+3%	+$7.44M	0.03%	414
2020 Q1	$226M	Buy	5,812,663 +468,109	+9%	+$23.9M	0.04%	378
2019 Q4	$302M	Sell	5,344,554 -179,004	-3%	-$9.98M	0.04%	392
2019 Q3	$294M	Buy	5,523,558 +51,935	+0.9%	+$2.79M	0.04%	371
2019 Q2	$319M	Buy	5,471,623 +87,294	+2%	+$4.69M	0.04%	361
2019 Q1	$267M	Buy	5,384,329 +423,084	+9%	+$18.6M	0.04%	393
2018 Q4	$185M	Sell	4,961,245 -1,188,305	-19%	-$43.2M	0.03%	454
2018 Q3	$232M	Buy	6,149,550 +3,298,864	+116%	+$137M	0.03%	448
2018 Q2	$125M	Sell	2,850,686 -463,840	-14%	-$21.8M	0.02%	600
2018 Q1	$167M	Sell	3,314,526 -3,784,915	-53%	-$223M	0.03%	504
2017 Q4	$467M	Sell	7,099,441 -5,255	-0.1%	-$334K	0.08%	269
2017 Q3	$425M	Sell	7,104,696 -4,216,945	-37%	-$251M	0.07%	283
2017 Q2	$734M	Sell	11,321,641 -78,517	-0.7%	-$4.96M	0.13%	179
2017 Q1	$712M	Sell	11,400,158 -2,272,535	-17%	-$137M	0.13%	179
2016 Q4	$789M	Sell	13,672,693 -453,610	-3%	-$26.8M	0.16%	156
2016 Q3	$840M	Buy	14,126,303 +850,914	+6%	+$52.3M	0.17%	144
2016 Q2	$824M	Buy	13,275,389 +379,836	+3%	+$23.4M	0.17%	145
2016 Q1	$795M	Buy	12,895,553 +2,688,238	+26%	+$158M	0.17%	148
2015 Q4	$621M	Buy	10,207,315 +167,207	+2%	+$9.95M	0.13%	179
2015 Q3	$508M	Buy	10,040,108 +100,715	+1%	+$5.36M	0.11%	207
2015 Q2	$512M	Sell	9,939,393 -834,313	-8%	-$43.2M	0.11%	224
2015 Q1	$548M	Sell	10,773,706 -3,533,446	-25%	-$182M	0.11%	217
2014 Q4	$762M	Sell	14,307,152 -1,609,207	-10%	-$81.9M	0.16%	161
2014 Q3	$726M	Sell	15,916,359 -139,146	-0.9%	-$6.55M	0.16%	159
2014 Q2	$760M	Sell	16,055,505 -2,569,342	-14%	-$120M	0.16%	155
2014 Q1	$857M	Sell	18,624,847 -2,567,703	-12%	-$119M	0.19%	136
2013 Q4	$1.03B	Buy	21,192,550 +75,312	+0.4%	+$3.52M	0.24%	114
2013 Q3	$917M	Buy	21,117,238 +48,070	+0.2%	+$2.05M	0.23%	113
2013 Q2	$863M	Buy	+21,069,168	New	+$878M	0.23%	111

Other funds holding XRAY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

SCA

Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

T. Rowe Price Associates's XRAY Position: Q1 2026 in Review

T. Rowe Price Associates increased its Dentsply Sirona (XRAY) stake by 8.9% in Q1 2026, buying an estimated $203K and bringing the position to 199,965 shares worth $2.32M. The position accounts for ﹤0.01% of the portfolio, ranked #1761.

T. Rowe Price Associates first reported a position in XRAY in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.16B in Q2 2021. 382 funds tracked by Wall St. Rank hold XRAY as of Q1 2026.

T. Rowe Price Associates held 199,965 shares of Dentsply Sirona worth $2.32M as of Q1 2026.
T. Rowe Price Associates bought 16,292 Dentsply Sirona shares in Q1 2026, an estimated $203K.
Dentsply Sirona made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #1761 holding.
T. Rowe Price Associates first reported a position in Dentsply Sirona in Q2 2013 and has held it in 52 quarters since.
T. Rowe Price Associates's Dentsply Sirona position peaked at $1.16B in Q2 2021.
382 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.